Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Diabetes may lower the risk of prostate cancer.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Finasteride improves prostate cancer detection in PSA test.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Finasteride reduces PSA levels by around 40-50% in BPH patients.